169 related articles for article (PubMed ID: 31652338)
21. MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas.
Bai J; Shi J; Zhang S; Zhang C; Zhai Y; Wang S; Li M; Li C; Zhao P; Geng S; Gui S; Jing L; Zhang Y
AJNR Am J Neuroradiol; 2020 May; 41(5):852-858. PubMed ID: 32381547
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract][Full Text] [Related]
23. Chordoma of the skull base: predictors of tumor recurrence.
Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
25. Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature.
Frankl J; Grotepas C; Stea B; Lemole GM; Chiu A; Khan R
J Med Case Rep; 2016 Oct; 10(1):280. PubMed ID: 27729085
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic Approach to Clival Chordomas: The Northwestern Experience.
Rahme RJ; Arnaout OM; Sanusi OR; Kesavabhotla K; Chandler JP
World Neurosurg; 2018 Feb; 110():e231-e238. PubMed ID: 29104156
[TBL] [Abstract][Full Text] [Related]
27. The Significance of Intraoperative Magnetic Resonance Imaging in Resection of Skull Base Chordomas.
Metwali H; Samii A; Gerganov V; Giordano M; Fahlbusch R; Samii M
World Neurosurg; 2019 Aug; 128():e185-e194. PubMed ID: 31003024
[TBL] [Abstract][Full Text] [Related]
28. Gamma knife radiosurgery for residual skull base chordomas.
Liu AL; Wang ZC; Sun SB; Wang MH; Luo B; Liu P
Neurol Res; 2008 Jul; 30(6):557-61. PubMed ID: 18647493
[TBL] [Abstract][Full Text] [Related]
29. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
Luo P; Wang X; Zhou J; Li L; Jing Z
Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
[TBL] [Abstract][Full Text] [Related]
30. Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index.
Holton JL; Steel T; Luxsuwong M; Crockard HA; Revesz T
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):497-503. PubMed ID: 11123715
[TBL] [Abstract][Full Text] [Related]
31. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
32. [Chordomas of the base of the skull and upper cervical spine. 100 patients irradiated by a 3D conformal technique combining photon and proton beams].
Noël G; Feuvret L; Dhermain F; Mammar H; Haie-Méder C; Ponvert D; Hasboun D; Ferrand R; Nauraye C; Boisserie G; Beaudré A; Gaboriaud G; Mazal A; Touboul E; Habrand JL; Mazeron JJ
Cancer Radiother; 2005 May; 9(3):161-74. PubMed ID: 15979920
[TBL] [Abstract][Full Text] [Related]
33. Surgical resection of skull-base chordomas: experience in case selection for surgical approach according to anatomical compartments and review of the literature.
Shimony N; Gonen L; Shofty B; Abergel A; Fliss DM; Margalit N
Acta Neurochir (Wien); 2017 Oct; 159(10):1835-1845. PubMed ID: 27924417
[TBL] [Abstract][Full Text] [Related]
34. Chordomas and chondrosarcomas of the skull base: treatment and outcome analysis in a consecutive case series of 24 patients.
Metcalfe C; Muzaffar J; Kulendra K; Sanghera P; Shaw S; Shad A; Saravanappa N; Paluzzi A; Ahmed S
World J Surg Oncol; 2021 Mar; 19(1):68. PubMed ID: 33750413
[TBL] [Abstract][Full Text] [Related]
35. Natural Growth Dynamics of Untreated Skull Base Chordomas In Vivo.
Wang K; Xie SN; Wang L; Du J; Ma JP; Huo XL; Tian KB; Zhang LW; Zhang JT; Wu Z
World Neurosurg; 2020 Apr; 136():e310-e321. PubMed ID: 31926359
[TBL] [Abstract][Full Text] [Related]
36. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
37. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
[TBL] [Abstract][Full Text] [Related]
38. Sarcomatous transformation of clival chordoma after charged-particle radiotherapy. Report of two cases.
Hara T; Kawahara N; Tsuboi K; Shibahara J; Ushiku T; Kirino T
J Neurosurg; 2006 Jul; 105(1):136-41. PubMed ID: 16871889
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of an endoscopic transclival and transpetrosal approach for primary skull base malignancies involving the clivus.
Kim YH; Jeon C; Se YB; Hong SD; Seol HJ; Lee JI; Park CK; Kim DG; Jung HW; Han DH; Nam DH; Kong DS
J Neurosurg; 2018 May; 128(5):1454-1462. PubMed ID: 28574308
[TBL] [Abstract][Full Text] [Related]
40. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
